KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 16,682 Value ($000) $340 Avg Close $17.54 Range $13.60 - $22.55
Q3 2025
Shares 19,749 Value ($000) $312 Avg Close $14.77 Range $13.13 - $16.30
Q2 2025
Shares 19,749 Value ($000) $264 Avg Close $13.50 Range $9.12 - $15.40
Q1 2025
Shares 18,098 Value ($000) $184 Avg Close $11.61 Range $9.71 - $16.70
Q4 2024
Shares 18,098 Value ($000) $286 Avg Close $51.97 Range $15.33 - $72.37
Q3 2024
Shares 17,071 Value ($000) $991 Avg Close $49.39 Range $40.93 - $59.06
Q2 2024
Shares 17,071 Value ($000) $780 Avg Close $53.73 Range $43.30 - $67.30
Q1 2024
Shares 13,143 Value ($000) $870 Avg Close $59.30 Range $39.00 - $73.00
Q4 2023
Shares 11,885 Value ($000) $473 Avg Close $31.36 Range $27.02 - $41.92
Q3 2023
Shares 11,885 Value ($000) $379 Avg Close $37.33 Range $31.17 - $44.95
Q2 2023
Shares 11,885 Value ($000) $478 Avg Close $43.84 Range $37.03 - $51.16
Q1 2023
Shares 10,097 Value ($000) $431 Avg Close $50.51 Range $39.98 - $59.96
Q4 2022
Shares 10,097 Value ($000) $485 Avg Close $46.71 Range $37.40 - $52.78
Q3 2022
Shares 8,455 Value ($000) $318 Avg Close $34.66 Range $26.34 - $42.15
Q2 2022
Shares 8,455 Value ($000) $234 Avg Close $43.88 Range $24.38 - $68.29
Q1 2022
Shares 8,455 Value ($000) $460 Avg Close $51.33 Range $39.75 - $60.42
Q4 2021
Shares 5,456 Value ($000) $319 Avg Close $49.87 Range $36.13 - $63.47
Q3 2021
Shares 5,456 Value ($000) $216 Avg Close $35.59 Range $28.50 - $44.87
Q2 2021
Shares 5,456 Value ($000) $232 Avg Close $54.17 Range $41.88 - $71.74
Q1 2021
Shares 5,456 Value ($000) $336 Avg Close $63.36 Range $51.48 - $75.99
Q4 2020
Shares 5,456 Value ($000) $385 Avg Close $63.02 Range $34.17 - $88.80
Q3 2020
Shares 3,810 Value ($000) $147 Avg Close $39.66 Range $25.71 - $65.50
Q2 2020
Shares 3,810 Value ($000) $143 Avg Close $30.81 Range $19.10 - $42.26